Table 2. Correlation Between Survival and Patient, Tumor and Treatment Characteristicsa.
Variables | No | Mean OS, mon | P Value | No | Mean EFS, mon | P Value |
---|---|---|---|---|---|---|
Gender | 0.785 | 0.425 | ||||
Female | 23 | 49 | 24 | 42 | ||
Male | 80 | 55 | 81 | 48 | ||
Age, y | 0.130 | 0.779 | ||||
≤ 50 | 28 | 61 | 29 | 50 | ||
> 50 | 75 | 51 | 76 | 46 | ||
BMI classification | 0.808 | 0.035 | ||||
Bellow normal | 13 | 46 | 13 | 26 | ||
Normal | 61 | 56 | 62 | 51 | ||
Above normal | 29 | 47 | 30 | 45 | ||
Primary tumor site | 0.417 | 0.096 | ||||
Larynx | 57 | 59 | 58 | 54 | ||
Non-larynx | 46 | 49 | 47 | 40 | ||
T-stage | 0.039 | 0.742 | ||||
T1/T2 | 56 | 59 | 57 | 48 | ||
T3/T4 | 46 | 47 | 47 | 45 | ||
N-stage | 0.101 | 0.043 | ||||
N0/N1 | 50 | 57 | 52 | 55 | ||
N2/N3 | 50 | 49 | 50 | 40 | ||
Treatment modality | 0.930 | 0.654 | ||||
Surgical | 58 | 56 | 59 | 48 | ||
Non-surgical | 38 | 54 | 39 | 50 |
aAbbreviations: BMI, body mass index; EFS, event free survival; N-stage, lymph node stage; OS, overall survival; T-stage, tumor stage.